Cornerstone Planning Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Cornerstone Planning Group’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-231	Closed	–	–	1393
2024 Q2	$0	Hold	231	–	–	﹤0.01%	1364
2024 Q1	$3.46K	Buy	+231	New	+$3.25K	﹤0.01%	579

Cornerstone Planning Group's MACK Position: Q3 2024 in Review

Cornerstone Planning Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 231 shares.

Cornerstone Planning Group first reported a position in MACK in Q1 2024 and held it in 2 quarters. The position peaked at $3.46K in Q1 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.

Cornerstone Planning Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
Cornerstone Planning Group sold 231 Merrimack Pharmaceuticals, Inc. shares in Q3 2024.
Cornerstone Planning Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2024 and held it in 2 quarters.
Cornerstone Planning Group's Merrimack Pharmaceuticals, Inc. position peaked at $3.46K in Q1 2024.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.

Based on Cornerstone Planning Group's 13F filing for Q3 2024, filed 5 Nov 2024.